黄芪注射液治疗小儿肾病综合征继发性免疫功能低下

Astragalus Membranaceus in Treatment of Secondary Immunodiefficiency

目的 :观察黄芪注射液治疗继发性免疫功能低下的疗效。方法 :肾病综合征引起的继发性免疫功能低下的病人 76例随机分为 2组。治疗组 36例 ,采用免疫抑制剂加黄芪注射液治疗 ;对照组 4 0例仅给免疫抑制剂治疗。结果 :治疗组治疗后血清IgG、IgA均明显上升 ,与对照组比较 ,差异有非常显著意义 (P <0 0 1)。治疗组总有效率为 88 9% ,对照组总有效率为 15%。结论

Aim:To observe the curative effect of Astragali Injection on secondary immunodiefficiency Methods:Patients(M52,F24;age 7 4±s5 1a)with secondary immunodiefficiency caused by nephrosis syndrome were randomly divided into 2 groups. The 36 patients of treatment group were treated with immunosuppressant and Astragali Injection 0 4ml/kg.d+5%GS 100ml iv qd for 20d, and the other 40 patients of control group were treated with only immunosuppressant Results:Serum IgG, IgA of the treatment group rose significantly after treatment, and the total effective rate was 89 4%, superier to that before treatment ( P <0 01), and of control group ( P <0 01) Conclusion: The Astragali Injection is an another choice of drugs in treatment of secondary immunodiefficiency caused by nephrosis syndrome.